Saltar al contenido
Merck

Vasodilator effects of ibudilast on retinal blood vessels in anesthetized rats.

Biological & pharmaceutical bulletin (2009-11-03)
Masahiro Noguchi, Asami Mori, Kenji Sakamoto, Tsutomu Nakahara, Kunio Ishii
RESUMEN

Ibudilast (3-isobutyryl-2-isopropylpyrazolo[1,5-alpha]pyridine) is clinically used as a cerebral vasodilator in Japan. However, the effects of ibudilast on retinal blood vessels have not been fully examined. The aim of this study, therefore, was to examine the effects of ibudilast on retinal blood vessels in rats in vivo. Male Wistar rats (8 to 10 weeks old) were anesthetized with thiobutabarbital (120 mg/kg, intraperitoneally (i.p.)). Retinal vascular images were captured with a fundus camera system for small animals, and the diameter of retinal blood vessels was measured. Ibudilast (0.1 and 1 mg/kg, intravenously (i.v.)) elicited a sustained increase in the diameter of retinal blood vessels and heart rate without altering systemic blood pressure. The effects of ibudilast were significantly reduced by treatment with the nonselective cyclooxygenase inhibitor indomethacin (5 mg/kg, i.p.). These results suggest that ibudilast dilates retinal blood vessels through cyclooxygenase-dependent mechanisms in rats in vivo.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Ibudilast, ≥99% (HPLC), solid